Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PERFECT JR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, P; Cardenas, ME; Cox, CM; Perfect, JR; Heitman, J
      Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans

      EMBO REPORTS
    2. Pappas, PG; Perfect, JR; Cloud, GA; Larsen, RA; Pankey, GA; Lancaster, DJ; Henderson, H; Kauffman, CA; Haas, DW; Saccente, M; Hamill, RJ; Holloway, MS; Warren, RM; Dismukes, WE
      Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

      CLINICAL INFECTIOUS DISEASES
    3. Perfect, JR; Cox, GM; Lee, JY; Kauffman, CA; de Repentigny, L; Chapman, SW; Morrison, VA; Pappas, P; Hiemenz, JW; Stevens, DA
      The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis

      CLINICAL INFECTIOUS DISEASES
    4. Wills, EA; Roberts, IS; Del Poeta, M; Rivera, J; Casadevall, A; Cox, GM; Perfect, JR
      Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity

      MOLECULAR MICROBIOLOGY
    5. Cox, GM; McDade, HC; Chen, SCA; Tucker, SC; Gottfredsson, M; Wright, LC; Sorrell, TC; Leidich, SD; Casadevall, A; Ghannoum, MA; Perfect, JR
      Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans

      MOLECULAR MICROBIOLOGY
    6. Luberto, C; Toffaletti, DL; Wills, EA; Tucker, SC; Casadevall, A; Perfect, JR; Hannun, YA; Del Poeta, M
      Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C-neoformans

      GENES & DEVELOPMENT
    7. D'Souza, CA; Alspaugh, JA; Yue, CL; Harashima, T; Cox, GM; Perfect, JR; Heitman, J
      Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans

      MOLECULAR AND CELLULAR BIOLOGY
    8. Cruz, MC; Goldstein, AL; Blankenship, J; Del Poeta, M; Perfect, JR; McCusker, JH; Bennani, YL; Cardenas, ME; Heitman, J
      Rapamycin and less immunosuppressive analogs are toxic to Candida albicansand Cryptococcus neoformans via FKBP12-dependent inhibition of TOR

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. Gottfredsson, M; Jessup, CJ; Cox, GM; Perfect, JR; Ghannoum, MA
      Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    10. Palmer, SM; Drew, RH; Whitehouse, JD; Tapson, VF; Davis, RD; McConnell, RR; Kanj, SS; Perfect, JR
      Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

      TRANSPLANTATION
    11. Stephens, CE; Tanious, F; Kim, S; Wilson, WD; Schell, WA; Perfect, JR; Franzblau, SG; Boykin, DW
      Diguanidino and "reversed" diamidino 2,3-diarylfurans as antimicrobial agents

      JOURNAL OF MEDICINAL CHEMISTRY
    12. Deepe, GS; Romani, L; Calich, VLG; Huffnagle, G; Arruda, C; Molinari-Madlum, EEIW; Perfect, JR
      Knockout mice as experimental models of virulence

      MEDICAL MYCOLOGY
    13. Saag, MS; Graybill, RJ; Larsen, RA; Pappas, PG; Perfect, JR; Powderly, WG; Sobel, JD; Dismukes, WE
      Practice guidelines for the management of cryptococcal disease

      CLINICAL INFECTIOUS DISEASES
    14. Nichols, WG; McCann, RL; Perfect, JR
      Tuberculous pseudoaneurysm of the thoracoabdominal aorta: Case and review

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    15. Alspaugh, JA; Cavallo, LM; Perfect, JR; Heitman, J
      RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans

      MOLECULAR MICROBIOLOGY
    16. Drew, RH; Perfect, JR; Srinath, L; Kurkimilis, E; Dowzicky, M; Talbot, GH
      Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy

      Journal of antimicrobial chemotherapy
    17. Dodds, ES; Drew, RH; Perfect, JR
      Antifungal pharmacodynamics: Review of the literature and clinical applications

      PHARMACOTHERAPY
    18. Gottfredsson, M; Perfect, JR
      Fungal meningitis

      SEMINARS IN NEUROLOGY
    19. Wang, P; Perfect, JR; Heitman, J
      The G-protein beta subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans

      MOLECULAR AND CELLULAR BIOLOGY
    20. Gorlach, J; Fox, DS; Cutler, NS; Cox, GM; Perfect, JR; Heitman, J
      Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans

      EMBO JOURNAL
    21. Del Poeta, M; Cruz, MC; Cardenas, ME; Perfect, JR; Heitman, J
      Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    22. Cruz, MC; Del Poeta, M; Wang, P; Wenger, R; Zenke, G; Quesniaux, VFJ; Movva, NR; Perfect, JR; Cardenas, ME; Heitman, J
      Immunosuppressive and nonimmunosuppressive clyclosporine analogs are toxicto the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    23. Luna, B; Drew, RH; Perfect, JR
      Agents for treatment of invasive fungal infections

      OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
    24. Lengeler, KB; Wang, P; Cox, GM; Perfect, JR; Heitman, J
      Identification of the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    25. Gottfredson, M; Cox, GM; Perfect, JR
      Oropharyngeal Candida colonization and human immunodeficiency virus type 1infection - Reply

      JOURNAL OF INFECTIOUS DISEASES
    26. Cox, GM; Mukherjee, J; Cole, GT; Casadevall, A; Perfect, JR
      Urease as a virulence factor in experimental cryptococcosis

      INFECTION AND IMMUNITY
    27. Cardenas, ME; Cruz, MC; Del Poeta, M; Chung, NJ; Perfect, JR; Heitman, J
      Antifungal activities of antineoplastic agents Saccharomyces cerevisiae asa model system to study drug action

      CLINICAL MICROBIOLOGY REVIEWS
    28. Powderly, WG; Gallant, JE; Ghannoum, MA; Mayer, KH; Navarro, EE; Perfect, JR
      Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    29. Powderly, WG; Mayer, KH; Perfect, JR
      Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: A critical reassessment

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    30. Del Poeta, M; Bixel, AS; Barchiesi, F; Tidwell, RR; Boykin, D; Scalise, G; Perfect, JR
      In-vitro activity of dicationic aromatic compounds and fluconazole againstCryptococcus neoformans and Candida spp.

      Journal of antimicrobial chemotherapy
    31. Heitman, J; Casadevall, A; Lodge, JK; Perfect, JR
      The Cryptococcus neoformans genome sequencing project

      MYCOPATHOLOGIA
    32. Cruz, MC; Cavallo, LM; Gorlach, JM; Cox, G; Perfect, JR; Cardenas, ME; Heitman, J
      Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans

      MOLECULAR AND CELLULAR BIOLOGY
    33. Asai, K; Tsuchimori, N; Okonogi, K; Perfect, JR; Gotoh, O; Yoshida, Y
      Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    34. Del Poeta, M; Chen, SF; Von Hoff, D; Dykstra, CC; Wani, MC; Manikumar, G; Heitman, J; Wall, ME; Perfect, JR
      Comparison of in vitro activities of camptothecin and nitidine derivativesagainst fungal and cancer cells

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    35. Gottfredsson, M; Cox, GM; Indridason, OS; de Almeida, GMD; Heald, AE; Perfect, JR
      Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization

      JOURNAL OF INFECTIOUS DISEASES
    36. Thompson, JR; Douglas, CM; Li, WL; Jue, CK; Pramanik, B; Yuan, XL; Rude, TH; Toffaletti, DL; Perfect, JR; Kurtz, M
      A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function

      JOURNAL OF BACTERIOLOGY
    37. Del Poeta, M; Toffaletti, DL; Rude, TH; Sparks, SD; Heitman, J; Perfect, JR
      Cryptococcus neoformans differential gene expression detected in vitro andin vivo with green fluorescent protein

      INFECTION AND IMMUNITY
    38. Yue, CL; Cavallo, LM; Alspaugh, JA; Wang, P; Cox, GM; Perfect, JR; Heitman, J
      The STE12 alpha homolog is required for haploid filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans

      GENETICS
    39. Del Poeta, M; Toffaletti, DL; Rude, TH; Dykstra, CC; Heitman, J; Perfect, JR
      Topoisomerase I is essential in Cryptococcus neoformans: Role in pathobiology and as an antifungal target

      GENETICS
    40. PERFECT JR; WONG B; CHANG YC; KWONCHUNG KJ; WILLIAMSON PR
      CRYPTOCOCCUS-NEOFORMANS - VIRULENCE AND HOST DEFENSES

      MEDICAL MYCOLOGY
    41. ALSPAUGH JA; PERFECT JR; HEITMAN J
      SIGNAL-TRANSDUCTION PATHWAYS REGULATING DIFFERENTIATION AND PATHOGENICITY OF CRYPTOCOCCUS-NEOFORMANS

      Fungal genetics and biology (Print)
    42. WALSH TJ; HIEMENZ JW; SEIBEL NL; PERFECT JR; HORWITH G; LEE L; SILBER JL; DINUBILE MJ; REBOLI A; BOW E; LISTER J; ANAISSIE EJ
      AMPHOTERICIN-B LIPID COMPLEX FOR INVASIVE FUNGAL-INFECTIONS - ANALYSIS OF SAFETY AND EFFICACY IN 556 CASES

      Clinical infectious diseases
    43. PALMER SM; PERFECT JR; HOWELL DN; LAWRENCE CM; MIRALLES AP; DAVIS RD; TAPSON VF
      CANDIDAL ANASTOMOTIC INFECTION IN LUNG-TRANSPLANT RECIPIENTS - SUCCESSFUL TREATMENT WITH A COMBINATION OF SYSTEMIC AND INHALED ANTIFUNGAL AGENTS

      The Journal of heart and lung transplantation
    44. JOHNSON MD; DREW RH; PERFECT JR
      CHEST DISCOMFORT ASSOCIATED WITH LIPOSOMAL AMPHOTERICIN-B - REPORT OF3 CASES AND REVIEW OF THE LITERATURE

      Pharmacotherapy
    45. DELPOETA M; SCHELL WA; DYKSTRA CC; JONES S; TIDWELL RR; CZARNY A; BAJIC M; BAJIC M; KUMAR A; BOYKIN D; PERFECT JR
      STRUCTURE IN-VITRO ACTIVITY RELATIONSHIPS OF PENTAMIDINE ANALOGS AND DICATION-SUBSTITUTED BIS-BENZIMIDAZOLES AS NEW ANTIFUNGAL AGENTS

      Antimicrobial agents and chemotherapy
    46. DELPOETA M; SCHELL WA; DYKSTRA CC; JONES SK; TIDWELL RR; KUMAR A; BOYKIN DW; PERFECT JR
      IN-VITRO ANTIFUNGAL ACTIVITIES OF A SERIES OF DICATION-SUBSTITUTED CARBAZOLES, FURANS, AND BENZIMIDAZOLES

      Antimicrobial agents and chemotherapy
    47. SCHELL WA; DEALMEIDA GMD; DODGE RK; OKONOGI K; PERFECT JR
      IN-VITRO AND IN-VIVO EFFICACY OF THE TRIAZOLE TAK-187 AGAINST CRYPTOCOCCUS-NEOFORMANS

      Antimicrobial agents and chemotherapy
    48. GOTTFREDSSON M; COX GM; PERFECT JR
      MOLECULAR METHODS FOR EPIDEMIOLOGIC AND DIAGNOSTIC STUDIES OF FUNGAL-INFECTIONS

      Pathology
    49. FIRESTINE SM; MISIALEK S; TOFFALETTI DL; KLEM TJ; PERFECT JR; DAVISSON VJ
      BIOCHEMICAL ROLE OF THE CRYPTOCOCCUS-NEOFORMANS ADE2 PROTEIN IN FUNGAL DE-NOVO PURINE BIOSYNTHESIS

      Archives of biochemistry and biophysics
    50. SCHELL WA; LIU K; HOWELL DN; PERFECT JR
      THE PHENOMENON OF ADVENTITIOUS SPORULATION

      AJCP. American journal of clinical pathology
    51. LIU K; HOWELL DN; PERFECT JR; SCHELL WA
      MORPHOLOGIC CRITERIA FOR THE PRELIMINARY IDENTIFICATION OF FUSARIUM, PAECILOMYCES, AND ACREMONIUM SPECIES BY HISTOPATHOLOGY

      AJCP. American journal of clinical pathology
    52. ALSPAUGH JA; PERFECT JR
      INFECTIONS DUE TO ZYGOMYCETES AND OTHER RARE FUNGAL OPPORTUNISTS

      Seminars in respiratory and critical care medicine
    53. ALSPAUGH JA; PERFECT JR; HEITMAN J
      CRYPTOCOCCUS-NEOFORMANS MATING AND VIRULENCE ARE REGULATED BY THE G-PROTEIN ALPHA-SUBUNIT GPA1 AND CAMP

      Genes & development
    54. TOFFALETTI DL; PERFECT JR
      STUDY OF CRYPTOCOCCUS-NEOFORMANS ACTIN GENE-REGULATION WITH A BETA-GALACTOSIDASE-ACTIN FUSION

      Journal of medical and veterinary mycology
    55. DELPOETA M; SCHELL WA; PERFECT JR
      IN-VITRO ANTIFUNGAL ACTIVITY OF PNEUMOCANDIN L-743,872 AGAINST A VARIETY OF CLINICALLY IMPORTANT MOLDS

      Antimicrobial agents and chemotherapy
    56. ALEXANDER BD; PERFECT JR
      ANTIFUNGAL RESISTANCE TRENDS TOWARDS THE YEAR 2000 - IMPLICATIONS FORTHERAPY AND NEW APPROACHES

      Drugs
    57. KAUFFMAN CA; PAPPAS PG; MCKINSEY DS; GREENFIELD RA; PERFECT JR; CLOUD GA; THOMAS CJ; DISMUKES WE; NEWMAN C; POWDERLY W; SCHELD M; SHARKEYMATHIS PK; CHAPMAN S; HAMILL R; LARSON R
      TREATMENT OF LYMPHOCUTANEOUS AND VISCERAL SPOROTRICHOSIS WITH FLUCONAZOLE

      Clinical infectious diseases
    58. PERFECT JR; SCHELL WA
      THE NEW FUNGAL OPPORTUNISTS ARE COMING

      Clinical infectious diseases
    59. FULLER RE; DREW RH; PERFECT JR
      TREATMENT OF VANCOMYCIN-RESISTANT ENTEROCOCCI, WITH A FOCUS ON QUINUPRISTIN-DALFOPRISTIN

      Pharmacotherapy
    60. HEALD AE; COX GM; SCHELL WA; BARTLETT JA; PERFECT JR
      OROPHARYNGEAL YEAST FLORA AND FLUCONAZOLE RESISTANCE IN HIV-INFECTED PATIENTS RECEIVING LONG-TERM CONTINUOUS VERSUS INTERMITTENT FLUCONAZOLE THERAPY

      AIDS
    61. COX GM; TOFFALETTI DL; PERFECT JR
      DOMINANT SELECTION SYSTEM FOR USE IN CRYPTOCOCCUS-NEOFORMANS

      Journal of medical and veterinary mycology
    62. SCHELL WA; PERFECT JR
      FATAL, DISSEMINATED ACREMONIUM-STRICTUM INFECTION IN A NEUTROPENIC HOST

      Journal of clinical microbiology
    63. PERFECT JR; COX GM; DODGE RK; SCHELL WA
      IN-VITRO AND IN-VIVO EFFICACIES OF THE AZOLE SCH56592 AGAINST CRYPTOCOCCUS-NEOFORMANS

      Antimicrobial agents and chemotherapy
    64. PERFECT JR
      FUNGAL VIRULENCE GENES AS TARGETS FOR ANTIFUNGAL CHEMOTHERAPY

      Antimicrobial agents and chemotherapy
    65. KANJ SS; WELTYWOLF K; MADDEN J; TAPSON V; BAZ MA; DAVIS RD; PERFECT JR
      FUNGAL-INFECTIONS IN LUNG AND HEART-LUNG TRANSPLANT RECIPIENTS - REPORT OF 9 CASES AND REVIEW OF THE LITERATURE

      Medicine
    66. SALAS SD; BENNETT JE; KWONCHUNG KJ; PERFECT JR; WILLIAMSON PR
      EFFECT OF THE LACCASE GENE, CNLAC1, ON VIRULENCE OF CRYPTOCOCCUS-NEOFORMANS

      The Journal of experimental medicine
    67. PERFECT JR; RUDE TH; WONG B; FLYNN T; CHATURVEDI V; NIEHAUS W
      IDENTIFICATION OF A CRYPROCOCCUS NEOFORMANS GENE THAT DIRECTS EXPRESSION OF THE CRYPTIC SACCHAROMYCES-CEREVISIAE MANNITOL DEHYDROGENASE GENE

      Journal of bacteriology
    68. BODILY K; PERFECT JR; PROCOP G; WASHINGTON MK; AFFRONTI J
      SMALL-INTESTINAL HISTOPLASMOSIS - SUCCESSFUL TREATMENT WITH ITRACONAZOLE IN AN IMMUNOCOMPETENT HOST

      Gastrointestinal endoscopy
    69. MORRIS A; SCHELL WA; MCDONAGH D; CHAFFEE S; PERFECT JR
      PNEUMONIA DUE TO FONSECAEA-PEDROSOI AND CEREBRAL ABSCESSES DUE TO EMERICELLA NIDULANS IN A BONE-MARROW TRANSPLANT RECIPIENT

      Clinical infectious diseases
    70. MITCHELL TG; PERFECT JR
      CRYPTOCOCCOSIS IN THE ERA OF AIDS - 100 YEARS AFTER THE DISCOVERY OF CRYPTOCOCCUS-NEOFORMANS

      Clinical microbiology reviews
    71. COX GM; RUDE TH; DYKSTRA CC; PERFECT JR
      THE ACTIN GENE FROM CRYPTOCOCCUS-NEOFORMANS - STRUCTURE AND PHYLOGENETIC ANALYSIS

      Journal of medical and veterinary mycology
    72. BERG D; GARCIA JA; SCHELL WA; PERFECT JR; MURRAY JC
      CUTANEOUS INFECTION CAUSED BY CURVULARIA-PALLESCENS - A CASE-REPORT AND REVIEW OF THE SPECTRUM OF DISEASE

      Journal of the American Academy of Dermatology
    73. PERFECT JR
      MOLECULAR TARGETS FOR NEW ANTIFUNGAL DRUGS

      Canadian journal of botany
    74. PERFECT JR
      ROLE OF CLASSIC DIMORPHIC PATHOGENS IN CONTEMPORARY MYCOSES

      Infectious diseases in clinical practice
    75. PERFECT JR; WRIGHT KA
      AMPHOTERICIN-B LIPID COMPLEX IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCAL MENINGITIS AND DISSEMINATED CANDIDOSIS

      Journal of antimicrobial chemotherapy
    76. COX GM; SCHELL WA; SCHER RL; PERFECT JR
      FIRST-REPORT OF INVOLVEMENT OF NODULISPORIUM SPECIES IN HUMAN-DISEASE

      Journal of clinical microbiology
    77. LODGE JK; JACKSONMACHELSKI E; TOFFALETTI DL; PERFECT JR; GORDON JI
      TARGETED GENE REPLACEMENT DEMONSTRATES THAT MYRISTOYL-COA PROTEIN N-MYRISTOYLTRANSFERASE IS ESSENTIAL FOR VIABILITY OF CRYPTOCOCCUS-NEOFORMANS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. DENNING DW; LEE JY; HOSTETLER JS; PAPPAS P; KAUFFMAN CA; DEWSNUP DH; GALGIANI JN; GRAYBILL JR; SUGAR AM; CATANZARO A; GALLIS H; PERFECT JR; DOCKERY B; DISMUKES WE; STEVENS DA
      NIAID MYCOSES STUDY-GROUP MULTICENTER TRIAL OF ORAL ITRACONAZOLE THERAPY FOR INVASIVE ASPERGILLOSIS (VOL 97, PG 135, 1994)

      The American journal of medicine
    79. DENNING DW; LEE JY; HOSTETLER JS; PAPPAS P; KAUFFMAN CA; DEWSNUP DH; GALGIANI JN; GRAYBILL JR; SUGAR AM; CATANZARO A; GALLIS H; PERFECT JR; DOCKERY B; DISMUKES WE; STEVENS DA
      NIAID MYCOSES STUDY-GROUP MULTICENTER TRIAL OF ORAL ITRACONAZOLE THERAPY FOR INVASIVE ASPERGILLOSIS

      The American journal of medicine
    80. COX GM; PERFECT JR
      FUNGAL-INFECTIONS

      Current opinion in infectious diseases
    81. INGRAM CW; HAYWOOD HB; MORRIS VM; ALLEN RL; PERFECT JR
      CRYPTOCOCCAL VENTRICULAR-PERITONEAL SHUNT INFECTION - CLINICAL AND EPIDEMIOLOGIC EVALUATION OF 2 CLOSELY ASSOCIATED CASES

      Infection control and hospital epidemiology
    82. PERFECT JR; SCHELL WA; RINALDI MG
      UNCOMMON INVASIVE FUNGAL PATHOGENS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      Journal of medical and veterinary mycology
    83. PERFECT JR; KETABCHI N; COX GM; INGRAM CW; BEISER CL
      KARYOTYPING OF CRYPTOCOCCUS-NEOFORMANS AS AN EPIDEMIOLOGIC TOOL

      Journal of clinical microbiology
    84. CAMERON ML; SCHELL WA; BRUCH S; BARTLETT JA; WASKIN HA; PERFECT JR
      CORRELATION OF IN-VITRO FLUCONAZOLE RESISTANCE OF CANDIDA ISOLATES INRELATION TO THERAPY AND SYMPTOMS OF INDIVIDUALS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Antimicrobial agents and chemotherapy
    85. PERFECT JR; TOFFALETTI DL; RUDE TH
      THE GENE ENCODING PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE (ADE2) IS ESSENTIAL FOR GROWTH OF CRYPTOCOCCUS-NEOFORMANS IN CEREBROSPINAL-FLUID

      Infection and immunity
    86. SHARKEYMATHIS PK; KAUFFMAN CA; GRAYBILL JR; STEVENS DA; HOSTETLER JS; CLOUD G; DISMUKES WE; BENNETT J; BRADSHER RW; CHAPMAN SW; FISHER JF; KERKERING TM; MEDOFF G; PERFECT JR; PANKEY GA; REX JH; SAAG MS
      TREATMENT OF SPOROTRICHOSIS WITH ITRACONAZOLE

      The American journal of medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:31:40